Objective:To observe the efficacy of entecavir in the treatment of chronic hepatitis B virus carriers(CHBc)from the immunological perspective and to provide the basis for the treatment of chronic hepatitis B virus carriers. Methods:Sixty-one chronic hepatitis B virus carriers were enrolled as experimental group,thirty chronic hepatitis B(CHB) were enrolled as positive control group,thirty healthy people were enrolled as normal control(NC) in this study. CHBc and CHB groups received entecavir for 24 weeks,wh...
【基金】
重庆市医学科研计划重点资助项目(编号:2015ZDXM008)
【更新日期】
2018-08-03
【分类号】
R512.62
【正文快照】
慢性乙型肝炎病毒携带者(chronic hepatitis Bvirus carriers,CHBc)是指乙型肝炎表面抗原(hep-atitis B surface antigen,HBs Ag)阳性持续6个月以上,乙型肝炎e抗原(hepatitis B envelope antigen,HBe Ag)阳性、HBV-DNA阳性、丙氨酸氨基转移酶(alanine aminotransferase,ALT)为?